Intellectual Property Rights and Research Tools in Molecular Biology PDF Download

Author: National Research Council
Publisher: Compass
ISBN:
Category : Business & Economics
Languages : en
Pages : 92

View

Book Description

Author: National Research Council
Publisher: National Academies Press
ISBN: 0309164885
Category : Science
Languages : en
Pages : 188

View

Book Description
The patenting and licensing of human genetic material and proteins represents an extension of intellectual property (IP) rights to naturally occurring biological material and scientific information, much of it well upstream of drugs and other disease therapies. This report concludes that IP restrictions rarely impose significant burdens on biomedical research, but there are reasons to be apprehensive about their future impact on scientific advances in this area. The report recommends 13 actions that policy-makers, courts, universities, and health and patent officials should take to prevent the increasingly complex web of IP protections from getting in the way of potential breakthroughs in genomic and proteomic research. It endorses the National Institutes of Health guidelines for technology licensing, data sharing, and research material exchanges and says that oversight of compliance should be strengthened. It recommends enactment of a statutory exception from infringement liability for research on a patented invention and raising the bar somewhat to qualify for a patent on upstream research discoveries in biotechnology. With respect to genetic diagnostic tests to detect patient mutations associated with certain diseases, the report urges patent holders to allow others to perform the tests for purposes of verifying the results.

Author: National Research Council
Publisher: National Academies Press
ISBN: 0309100674
Category : Science
Languages : en
Pages : 189

View

Book Description
The patenting and licensing of human genetic material and proteins represents an extension of intellectual property (IP) rights to naturally occurring biological material and scientific information, much of it well upstream of drugs and other disease therapies. This report concludes that IP restrictions rarely impose significant burdens on biomedical research, but there are reasons to be apprehensive about their future impact on scientific advances in this area. The report recommends 13 actions that policy-makers, courts, universities, and health and patent officials should take to prevent the increasingly complex web of IP protections from getting in the way of potential breakthroughs in genomic and proteomic research. It endorses the National Institutes of Health guidelines for technology licensing, data sharing, and research material exchanges and says that oversight of compliance should be strengthened. It recommends enactment of a statutory exception from infringement liability for research on a patented invention and raising the bar somewhat to qualify for a patent on upstream research discoveries in biotechnology. With respect to genetic diagnostic tests to detect patient mutations associated with certain diseases, the report urges patent holders to allow others to perform the tests for purposes of verifying the results.

Author: OECD
Publisher: OECD Publishing
ISBN: 9264034730
Category :
Languages : en
Pages : 112

View

Book Description
Few topics in the life sciences today provoke as much debate as the availability of patent protection on "genetic inventions". Some hold that protection is essential to encourage innovation and development of new products. Others argue that patents ...

Author: Matthew Rimmer
Publisher: Edward Elgar Publishing
ISBN: 1781001189
Category : Technology & Engineering
Languages : en
Pages : 499

View

Book Description
This unique and comprehensive collection investigates the challenges posed to intellectual property by recent paradigm shifts in biology. It explores the legal ramifications of emerging technologies, such as genomics, synthetic biology, stem cell research, nanotechnology, and biodiscovery. Extensive contributions examine recent controversial court decisions in patent law such as Bilski v. Kappos, and the litigation over Myriad's patents in respect of BRCA1 and BRCA2 while other papers explore sui generis fields, such as access to genetic resources, plant breeders' rights, and traditional knowledge. The collection considers the potential and the risks of the new biology for global challenges such as access to health-care, the protection of the environment and biodiversity, climate change, and food security. It also considers Big Science projects such as biobanks, the 1000 Genomes Project, and the Doomsday Vault. The inter-disciplinary research brings together the work of scholars from Australia, Canada, Europe, the UK and the US and involves not only legal analysis of case law and policy developments, but also historical, comparative, sociological, and ethical methodologies. Intellectual Property and Emerging Technologies will appeal to policy-makers, legal practitioners, business managers, inventors, scientists and researchers.

Author: F. Scott Kieff
Publisher: Academic Press
ISBN:
Category : Law
Languages : en
Pages : 576

View

Book Description
The groundbreaking work of modern genetics that culminated in the Human Genome Project has blazed new pathways in both science and law. As the assertion of property rights generally, and patents in particular, has become increasingly common surrounding the new products and processes of modern biotechnology, the transactions that must occur for downstream research and development to occur have shifted in important ways, in both academic and business settings. Perspectives on Properties of the Human Genome Project addresses the problems raised in this complex area under different regimes of laws and norms to offer hope and help as we wrestle to ensure optimal use of such essential innovations. This unique collection of authors, views, and topics is essential reading for academics, policy-makers, and practitioners in medicine, biology, sociology, management, ethics, law, and economics, and anyone else interested in gaining perspective on the broad interface between biotechnology and property. "This is a gem of a book... [by] a veritable 'who's who' of important contributors to this field.. An interested reader could not ask for a better overview and compendium of serious, thoughtful analysis of this important topic." - Professor Robert P. Merges, University of California at Berkeley School of Law "Kieff's timely and masterful book establishes a modern truth: to translate a scientific discovery into tangible patient benefits requires an intellectual property lawyer. [It] should be read not only by legal scholars but also scientists and the general public." - Dr. Mark Siegler, University of Chicago Pritzker School of Medicine

Author: Michael Wink
Publisher: John Wiley & Sons
ISBN: 3527672036
Category : Science
Languages : en
Pages : 711

View

Book Description
Molecular biotechnology continues to triumph, as this textbook testifies - edited by one of the academic pioneers in the field and written by experienced professionals. This completely revised second edition covers the entire spectrum, from the fundamentals of molecular and cell biology, via an overview of standard methods and technologies, the application of the various "-omics", and the development of novel drug targets, right up to the significance of system biology in biotechnology. The whole is rounded off by an introduction to industrial biotechnology as well as chapters on company foundation, patent law and marketing. The new edition features: - Large format and full color throughout - Proven structure according to basics, methods, main topics and economic perspectives - New sections on system biology, RNA interference, microscopic techniques, high throughput sequencing, laser applications, biocatalysis, current biomedical applications and drug approval - Optimized teaching with learning targets, a glossary containing around 800 entries, over 500 important abbreviations and further reading. The only resource for those who are seriously interested in the topic. Bonus material available online free of charge: www.wiley-vch.de/home/molecbiotech

Author: National Academies Policy Advisory Group
Publisher:
ISBN:
Category : Copyright
Languages : en
Pages : 88

View

Book Description
Intellectual property has attracted growing and persistent attention. The academic community, as a major generator of intellectual property, has special interests in the subject. Thus, intellectual property was selected as an important topic worthy of thorough investigation by the National Academies Policy Advisory Group (NAPAG). This is the first major report of NAPAG.

Author: National Research Council
Publisher: National Academies Press
ISBN: 0309184460
Category : Political Science
Languages : en
Pages : 68

View

Book Description
On January 27-28, 1999, the NRC Commission on Life Sciences organized "Finding the Path: Issues of Access to Research Resources", a conference to explore the breadth of problems and opportunities related to obtaining and transferring research resources. The following summary of the 2-day meeting lays out the problems concerning access to research resources as discussed by 2 dozen speakers and members of the audience.

Author: Antoinette F. Konski
Publisher: Biota Publishing
ISBN: 1615047433
Category : Law
Languages : en
Pages : 75

View

Book Description
Are stem cells patentable? What is the patenting process? What rights does a patent provide? Why should I patent? Applying for and obtaining a patent is a process that can be unpredictable and intimidating, although it does not necessarily need to be. Novice and experienced inventors often have questions regarding patenting and the patenting process. This e-book is provided to answer many questions regarding the patenting process before the United States Patent and Trademark Office (“USPTO”). It also generally describes the technologies typically patented in connection with regenerative medicine. This e-book is provided for informational purposes only and should not replace legal advice, which is necessary to anticipate and address the nuances of the patenting process. In addition, there are issues that should be considered and addressed when considering patenting isolated stem cells and associated technologies—such as the process for obtaining patent rights outside the United States, post-grant procedures for challenging patents, non-patent protection of intellectual property, and enforcement of patents through litigation—which are beyond the scope of this chapter.